WFC
63
3
FLS
56
-3
R
66
-4
CME
42
-4
CFG
38
-2
OMC
64
-2
ROK
44
-7
HIG
68
4
VRSN
53
-2
ETR
68
2
FIS
46
-4
SCHW
52
3
MS
64
7
VMC
57
-3
ALL
61
-2
CHK
48
15
D
60
5
EL
30
-3
BAC
41
-6
URI
58
-5
WFC
63
3
FLS
56
-3
R
66
-4
CME
42
-4
CFG
38
-2
OMC
64
-2
ROK
44
-7
HIG
68
4
VRSN
53
-2
ETR
68
2
FIS
46
-4
SCHW
52
3
MS
64
7
VMC
57
-3
ALL
61
-2
CHK
48
15
D
60
5
EL
30
-3
BAC
41
-6
URI
58
-5
Financhill
Back

TD U.S. Long Term Treasury Bond ETF Vs. Apellis Pharmaceuticals Industry Stock Comparison

Sell
30

TULB.TO
TD U.S. Long Term Treasury Bond ETF

Last Price:
120.75
Seasonality Move:
1.13%
Sell
19

APLS
Apellis Pharmaceuticals

Last Price:
32.49
Seasonality Move:
18.8%
Sell
30
TD U.S. Long Term Treasury Bond ETF (TULB.TO) is a Sell

Is TD U.S. Long Term Treasury Bond ETF a Buy, Sell or Hold?

  • The current TD U.S. Long Term Treasury Bond ETF [TULB.TO] share price is $120.75. The Score for TULB.TO is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • TULB.TO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
19
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

TULB.TO Stock Price Chart

What is TD U.S. Long Term Treasury Bond ETF's stock price today?

  • The TD U.S. Long Term Treasury Bond ETF share price today is $120.75
    The current trend is moderately bearish and TULB.TO is experiencing buying pressure, which is a positive indicator for future bullish movement.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $32.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

TULB.TO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.96 Buy
Relative Strength Index (14 RSI): 51.12 Buy
Chaikin Money Flow: 12605 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (118.91 - 122.23) Buy
Bollinger Bands (100): (112.08 - 119.68) Buy

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 33.6 Sell
Chaikin Money Flow: -1084788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.37 - 40.01) Sell
Bollinger Bands (100): (36.55 - 42.35) Sell

TULB.TO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 122.28 Sell
20-day SMA: 120.72 Buy
50-day SMA: 118.72 Buy
200-day SMA: 114.91 Buy
8-day EMA: 121.74 Sell
20-day EMA: 121.04 Sell
50-day EMA: 119.08 Buy
200-day EMA: 115.87 Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.19 Sell
20-day SMA: 38.04 Sell
50-day SMA: 37.88 Sell
200-day SMA: 50 Sell
8-day EMA: 35.96 Sell
20-day EMA: 37.21 Sell
50-day EMA: 38.25 Sell
200-day EMA: 45.7 Sell

TD U.S. Long Term Treasury Bond ETF Earnings Growth & TULB.TO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

TD U.S. Long Term Treasury Bond ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):